Correct Capital Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.57M Sell
14,587
-983
-6% -$229K 0.67% 23
2025
Q4
$3.22M Buy
15,570
+645
+4% +$128K 0.6% 24
2025
Q3
$2.77M Buy
14,925
+190
+1% +$32.6K 0.46% 29
2025
Q2
$2.25M Buy
14,735
+548
+4% +$84.2K 0.33% 32
2025
Q1
$2.35M Buy
14,187
+3,063
+28% +$479K 0.38% 26
2024
Q4
$1.61M Sell
11,124
-2,058
-16% -$319K 0.32% 36
2024
Q3
$2.14M Buy
13,182
+4,366
+50% +$696K 0.47% 23
2024
Q2
$1.29M Buy
8,816
+133
+2% +$19.8K 0.3% 37
2024
Q1
$1.37M Buy
8,683
+1,422
+20% +$226K 0.32% 35
2023
Q4
$1.14M Buy
+7,261
New +$1.11M 0.29% 37

Other funds holding JNJ

Correct Capital Wealth Management's JNJ Position: Q1 2026 in Review

Correct Capital Wealth Management reduced its Johnson & Johnson (JNJ) stake by 6.3% in Q1 2026, selling an estimated $229K and leaving 14,587 shares worth $3.57M. The position accounts for 0.67% of the portfolio, ranked #23.

Correct Capital Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Correct Capital Wealth Management held 14,587 shares of Johnson & Johnson worth $3.57M as of Q1 2026.
  • Correct Capital Wealth Management sold 983 Johnson & Johnson shares in Q1 2026, an estimated $229K.
  • Johnson & Johnson made up 0.67% of Correct Capital Wealth Management's portfolio in Q1 2026, its #23 holding.
  • Correct Capital Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Correct Capital Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.